EP1411976A2 - Impfstoff für veterinäre und humanmedizinische prophylaxe und therapie von dermatophytosen - Google Patents

Impfstoff für veterinäre und humanmedizinische prophylaxe und therapie von dermatophytosen

Info

Publication number
EP1411976A2
EP1411976A2 EP02767271A EP02767271A EP1411976A2 EP 1411976 A2 EP1411976 A2 EP 1411976A2 EP 02767271 A EP02767271 A EP 02767271A EP 02767271 A EP02767271 A EP 02767271A EP 1411976 A2 EP1411976 A2 EP 1411976A2
Authority
EP
European Patent Office
Prior art keywords
vaccine
strains
ccm
vaccination
vaccination strains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02767271A
Other languages
German (de)
English (en)
French (fr)
Inventor
Alois Rybnikar
Josef Chumela
Vladimir Vrzal
Libor Bittner
Evzen Weigl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioveta AS
Esteve Pharmaceuticals GmbH
Original Assignee
Bioveta AS
Riemser Arzneimittel AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioveta AS, Riemser Arzneimittel AG filed Critical Bioveta AS
Publication of EP1411976A2 publication Critical patent/EP1411976A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells

Definitions

  • Embodiments with the ratio a1: a2: a3: a4 of 4: 2: 10: 3 or 10: 1: 30: 2 and the ratios a1: a3: a4 of 1: 3 are very particularly preferred for human use. 1 and a2: a4 of 1: 2 or the sole use of a4 (Trichophyton rubrum CCM 8291).
  • the mixture of the strains a1: a2: a3: a4 corresponds to the ratio of 0 or 2-10: 0 or 1-5: 0 or 5-30: 0 or 2-10 in the end product, the abovementioned Mixing ratios and individual strains are particularly preferred.
  • Example 8 Preparation of a human medical vaccine and application

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP02767271A 2001-07-27 2002-07-29 Impfstoff für veterinäre und humanmedizinische prophylaxe und therapie von dermatophytosen Withdrawn EP1411976A2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20012732 2001-07-27
CZ20012732A CZ290509B6 (cs) 2001-07-27 2001-07-27 Vakcína proti dermatofytózám a způsob její výroby
PCT/EP2002/008435 WO2003011329A2 (de) 2001-07-27 2002-07-29 Impfstoff für veterinäre und humanmedizinische prophylaxe und therapie von dermatophytosen

Publications (1)

Publication Number Publication Date
EP1411976A2 true EP1411976A2 (de) 2004-04-28

Family

ID=5473491

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02767271A Withdrawn EP1411976A2 (de) 2001-07-27 2002-07-29 Impfstoff für veterinäre und humanmedizinische prophylaxe und therapie von dermatophytosen

Country Status (9)

Country Link
US (1) US20040151726A1 (cs)
EP (1) EP1411976A2 (cs)
JP (1) JP2004536146A (cs)
CN (1) CN1545417A (cs)
CA (1) CA2453831A1 (cs)
CZ (1) CZ290509B6 (cs)
PL (1) PL365029A1 (cs)
RU (1) RU2253467C1 (cs)
WO (1) WO2003011329A2 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2560572C2 (ru) * 2013-08-20 2015-08-20 Федеральное государственное унитарное предприятие "Ставропольская биофабрика" Способ производства вакцины для профилактики и терапии трихофитоза крупного рогатого скота
CN112877217B (zh) * 2020-12-10 2022-04-15 贵州大学 一种黄褐奈尼兹皮真菌菌株及其降解鸡毛中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO153458C (no) * 1978-06-07 1986-03-26 Inst Experimentalnoi Veterinar Fremgangsm¨te for fremstilling av vaksine for profylakse o g behandling av ringorm hos pelsdyr og kaniner for¨rsaket av trichophyton mentagrophytes.
CA2011896C (en) * 1989-04-21 2001-05-08 Mark Werner Ringworm vaccine
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
WO2001015725A1 (en) * 1998-09-24 2001-03-08 Alpharma As Vaccine for the protection of a vertebrate animal against fungal skin infection

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None *
See also references of WO03011329A3 *

Also Published As

Publication number Publication date
RU2253467C1 (ru) 2005-06-10
US20040151726A1 (en) 2004-08-05
WO2003011329A2 (de) 2003-02-13
CZ20012732A3 (cs) 2002-08-14
CZ290509B6 (cs) 2002-08-14
WO2003011329A3 (de) 2003-07-17
PL365029A1 (en) 2004-12-27
CA2453831A1 (en) 2003-02-13
CN1545417A (zh) 2004-11-10
JP2004536146A (ja) 2004-12-02
RU2003137591A (ru) 2005-03-27

Similar Documents

Publication Publication Date Title
AT408615B (de) Neue influenzavirus-impfstoffzusammensetzung
DE69735191T2 (de) Verfahren zur Herstellung multivalenter Impfstoffe
EP0304786A2 (de) Intranasale Impfung von Pferden mit inaktivierten Mikroorganismen oder antigenem Material
DE2817891A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
DE69021761T3 (de) Impfstoff gegen Tinea.
DE2923144C2 (de) Impfstoff zur Prophylaxe und Behandlung von durch Trichophyton mentagrophytes hervorgerufenen Trichophytien bei Pelztieren und Kaninchen und seine Herstellung
DE2423129A1 (de) Verfahren zur herstellung temperaturempfindlicher, nicht pathogener mutantenstaemme von rinder-adeno-virusstaemmen und diese virusstaemme enthaltende lebendvakzine
EP0445710B1 (de) Verwendung von Zink-Calciumhydroxid, Lecithin und PAO zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen
EP0564620B1 (de) Dermatomykose-vakzine
DE2655691C2 (de) Temperaturempfindliche, vermehrungsfähige, nicht pathogene Varicella-Zoster-Viren, Verfahren zu ihrer Herstellung und diese Viren enthaltende Lebendvaccine
DE2212277C3 (de) Verfahren zur Herstellung einer Totvaccine gegen infektiöse atrophische Rhinitis der Schweine
EP1411976A2 (de) Impfstoff für veterinäre und humanmedizinische prophylaxe und therapie von dermatophytosen
DE2816942C2 (de) Impfstoff gegen Rhinitis atrophicans beim Schwein
EP2327420A2 (de) Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens
DE69231724T2 (de) Fischimpfstoff gegen infektion mit aeromonas salmonicida
DE3034238A1 (de) Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben
DE1792256C3 (de) Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
DE60213785T2 (de) Saponin inaktivierte mykoplasma impfstoffe
EP0642796A1 (de) Salmonella-Lebendimpfstoff
DE2200376A1 (de) Vaccine gegen Streptococcus equi. und Verfahren zu deren Herstellung
DE2415353A1 (de) Verfahren zur herstellung von temperaturempfindlichen, nicht pathogenen mutanten von herpes simplex typ 2-viren und ihre verwendung zur herstellung von vaccinen
DE2602478B2 (de) Impfstoff gegen die Panleukopenie . der Feliden
DE2167168C2 (de) Flüssiges, Leberverdauungsbrühe, -extrakt oder -infusion enthaltendes Nährmedium zum anaeroben Züchten von Fusiformis nodosus und Verfahren zum anaeroben Züchten von Fusiformis nodusus
DE3345864A1 (de) Impfstoff und verfahren zu seiner herstellung
Kielstein Systematic control of dermatophytosis profunda of cattle in the former GDR

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040202

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17Q First examination report despatched

Effective date: 20070115

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070726